Stanford, CA, United States of America

Jiang Xia

This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2008.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 33(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiang Xia - Innovator in Celiac Disease Research

Introduction

Jiang Xia is a prominent inventor based in Stanford, CA (US). He has made significant contributions to the field of medical diagnostics and therapeutics, particularly concerning celiac disease. His innovative work focuses on the detection and treatment of conditions related to gluten intolerance.

Latest Patents

Jiang Xia holds 1 patent for his invention titled "Peptides for diagnostic and therapeutic methods for celiac sprue." This patent addresses the detection of toxic gluten oligopeptides that are resistant to digestion. It also highlights the role of antibodies and T cells that respond to these oligopeptides, which can be utilized to diagnose celiac sprue. Furthermore, analogs of these oligopeptides are noted for their potential in inhibiting immune responses.

Career Highlights

Jiang Xia is affiliated with Leland Stanford Junior University, where he conducts his research and development. His work has garnered attention for its potential impact on improving diagnostic methods and therapeutic strategies for individuals suffering from celiac disease.

Collaborations

Jiang Xia has collaborated with notable colleagues, including Chaitan Khosla and Matthew John Siegel. These partnerships have contributed to the advancement of research in the field of gluten-related disorders.

Conclusion

Jiang Xia's innovative contributions to the understanding and treatment of celiac disease exemplify the importance of research in medical science. His work not only aids in diagnosis but also opens avenues for therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…